pharmacokinetics of glp 1 receptor agonists A Comprehensive Review on the and Drug−Drug Interactions Approved GLP-1 and a Dual GLP-1/GIP Receptor Agonist A Comprehensive Review on the

Studies and meta-analyses have revealed that postprandial GLP-1 levels increase after the Roux-en-Y gastric bypass and sleeve gastrectomy, but fasting GLP-1 levels do not increase significantly

Could it be because Indian physicians are conservative when it comes to prescribing newer drugs

Although most of the studies reported an association between GLP-1 RA and increased residual gastric contents, evidence linking these medications to a statistically significant rise in regurgitation or aspiration events remains highly inconsistent

A 2026 analysis of 25 products found zero contained semaglutide

Although, in the last 10 years, the use of GLP-1 RAs, especially semaglutide and liraglutide, has increased, its clinical implications and how it affects metabolic parameters have yet to be fully consolidated